Abstract
Substance addiction can be a chronic relapsing disorder. While different drugs of addiction have different primary molecular targets, it has been demonstrated that many share the common action of being able to increase dopamine within hard-wired reward circuitry. While this effect is widely conceived as a primary factor driving initial drug use, long-term adaptations within this hard-wired neural circuitry underlie the transition from drug use to drug dependence. Significantly, these neuroadaptations are responsible for triggering recurrent drug relapse in people recovering from addiction, even when following periods of long-term abstinence. While there is no animal model of addiction that can fully emulate the human condition, some animal models do permit the investigation of specific elements of drug addiction, particularly those involving the reward system and its role in drug-seeking behavior. Neuroimaging methods now also permit us to test hypotheses of addiction derived from such animal models, allowing the field of neuroscience to examine neural components of drug abuse and dependence in humans. These neuroimaging procedures permit neuroscientists to test hypotheses in humans at different stages of the addiction cycle, particularly with a view to developing better treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abi-Dargham, A., Krystal, J. H., Anjilvel, S., Scanley, B. E., Zoghbi, S., Baldwin, R. M., et al. (1998). Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. The American Journal of Psychiatry, 155(11), 1550–1555.
Aharonovich, E., Nunes, E., & Hasin, D. (2003). Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug and Alcohol Dependence, 71(2), 207–211.
Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence, 81(3), 313–322.
Amara, S. G., & Kuhar, M. J. (1993). Neurotransmitter transporters: Recent progress. Annual Review of Neuroscience, 16, 73–93.
Bardo, M. T., & Bevins, R. A. (2000). Conditioned place preference: What does it add to our preclinical understanding of drug reward? Psychopharmacology, 153(1), 31–43.
Bechara, A. (2005). Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective. Nature Neuroscience, 8(11), 1458–1463.
Bechara, A., Damasio, A. R., Damasio, H., & Anderson, S. W. (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition, 50(1–3), 7–15.
Bechara, A., Dolan, S., Denburg, N., Hindes, A., Anderson, S. W., & Nathan, P. E. (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia, 39(4), 376–389.
Beck, A., Schlagenhauf, F., Wustenberg, T., Hein, J., Kienast, T., Kahnt, T., et al. (2009). Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biological Psychiatry, 66(8), 734–742.
Benowitz, N. L. (2008). Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics, 83(4), 531–541.
Benowitz, N. L. (2009). Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics. Annual Review of Pharmacology and Toxicology, 49, 57–71.
Berridge, K. C. (2009). Wanting and liking: Observations from the neuroscience and psychology laboratory. Inquiry (Oslo), 52(4), 378.
Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research. Brain Research Reviews, 28(3), 309–369.
Berridge, K. C., Robinson, T. E., & Aldridge, J. W. (2009). Dissecting components of reward: ‘Liking’, ‘wanting’, and learning. Current Opinion in Pharmacology, 9(1), 65–73.
Bickel, W., & Marsch, L. (2001). Toward a behavioral economic understanding of drug dependence: Delay discounting processes. Addiction, 96(1), 73–86.
Bickel, W. K., Miller, M. L., Yi, R., Kowal, B. P., Lindquist, D. M., & Pitcock, J. A. (2007). Behavioral and neuroeconomics of drug addiction: Competing neural systems and temporal discounting processes. Drug and Alcohol Dependence, 90(Suppl 1), S85–S91.
Bjork, J. M., Hommer, D. W., Grant, S. J., & Danube, C. (2004). Impulsivity in abstinent alcohol-dependent patients: Relation to control subjects and type 1-/type 2-like traits. Alcohol, 34(2–3), 133–150.
Bjork, J. M., Smith, A. R., & Hommer, D. W. (2008). Striatal sensitivity to reward deliveries and omissions in substance dependent patients. NeuroImage, 42(4), 1609–1621.
Blum, K., Braverman, E. R., Holder, J. M., Lubar, J. F., Monastra, V. J., Miller, D., et al. (2000). Reward deficiency syndrome: A biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of Psychoactive Drugs, 32(Suppl i–iv), 1–112.
Bolla, K. I., Eldreth, D. A., London, E. D., Kiehl, K. A., Mouratidis, M., Contoreggi, C., et al. (2003). Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. NeuroImage, 19, 1085–1094.
Bolla, K. I., Eldreth, D. A., Matochik, J. A., & Cadet, J. L. (2005). Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage, 26(2), 480–492.
Bossong, M. G., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R. C., Windhorst, A. D., et al. (2009). Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology, 34(3), 759–766.
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., et al. (2004). Smoking-induced ventral striatum dopamine release. The American Journal of Psychiatry, 161(7), 1211–1218.
Brody, A. L., Mandelkern, M. A., London, E. D., Olmstead, R. E., Farahi, J., Scheibal, D., et al. (2006). Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Archives of General Psychiatry, 63(8), 907–915.
Bruijnzeel, A. W. (2009). Kappa-Opioid receptor signaling and brain reward function. Brain Research Reviews, 62(1), 127–146.
Burger, L. Y., & Martin-Iverson, M. T. (1994). Increased occupation of D1 and D2 dopamine receptors accompanies cocaine-induced behavioral sensitization. Brain Research, 639(2), 228–232.
Cami, J., & Farre, M. (2003). Drug addiction. The New England Journal of Medicine, 349(10), 975–986.
Carter, C., Braver, T., Barch, D., Botvinick, M., Noll, D., & Cohen, J. D. (1998). Anterior cingulate cortex, error detection, and the online monitoring of performance. Science, 280(5364), 747–749.
Curran, H. V., Brignell, C., Fletcher, S., Middleton, P., & Henry, J. (2002). Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology, 164(1), 61–70.
D’Souza, D. C., Braley, G., Blaise, R., Vendetti, M., Oliver, S., Pittman, B., et al. (2008). Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology, 198(4), 587–603.
Dagher, A., Bleicher, C., Aston, J. A., Gunn, R. N., Clarke, P. B., & Cumming, P. (2001). Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse, 42(1), 48–53.
Daglish, M. R., Weinstein, A., Malizia, A. L., Wilson, S., Melichar, J. K., Britten, S., et al. (2001). Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. The American Journal of Psychiatry, 158(10), 1680–1686.
Daglish, M. R. C., Williams, T., Wilson, S. J., Taylor, L. G., Brooks, D. J., Myles, J. S., Grasby, P. G., Lingford-Hughes, A. R., & Nutt, D. J. (2008). No measurable dopamine response to heroin in the brains of human addicts. The British Journal of Psychiatry, 193(1), 65–72.
Degoulet, M. F., Rostain, J. C., David, H. N., & Abraini, J. H. (2009). Repeated administration of amphetamine induces a shift of the prefrontal cortex and basolateral amygdala motor function. The International Journal of Neuropsychopharmacology, 12(7), 965–974.
Ding, Y. S., Gatley, S. J., Thanos, P. K., Shea, C., Garza, V., Xu, Y., et al. (2004). Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration. Synapse, 53(3), 168–175.
Drenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., et al. (2010). Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors. Journal of Neuroscience, 30(29), 9877–9889.
Ernst, M., Bolla, K., Mouratidis, M., Contoreggi, C., Matochik, J. A., Kurian, V., et al. (2002). Decision-making in a risk-taking task: A PET study. Neuropsychopharmacology, 26(5), 682–691.
Everitt, B. J., & Robbins, T. W. (2005). Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nature Neuroscience, 8(11), 1481–1489.
Feltenstein, M. W., & See, R. E. (2008). The neurocircuitry of addiction: An overview. British Journal of Pharmacology, 154(2), 261–274.
Fergusson, D. M., Horwood, L. J., & Ridder, E. M. (2007). Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: Results of a 25-year longitudinal study. Drug and Alcohol Dependence, 88(Suppl 1), S14–S26.
Forman, S. D., Dougherty, G. G., Casey, B. J., Siegle, G. J., Braver, T. S., Barch, D. M., et al. (2004). Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biological Psychiatry, 55(5), 531–537.
Franklin, T., Wang, Z., Suh, J. J., Hazan, R., Cruz, J., Li, Y., et al. (2011). Effects of varenicline on smoking cue-triggered neural and craving responses. Archives of General Psychiatry, 68(5), 516–526.
Garavan, H., & Stout, J. C. (2005). Neurocognitive insights into substance abuse. Trends in Cognitive Science, 9(4), 195–201.
Garavan, H., Ross, T. J., & Stein, E. A. (1999). Right hemispheric dominance of inhibitory control: An event-related functional MRI study. Proceedings of the National Academy of Sciences of the United States of America, 96(14), 8301–8306.
Garavan, H., Ross, T. J., Murphy, K., Roche, R. A., & Stein, E. A. (2002). Dissociable executive functions in the dynamic control of behavior: Inhibition, error detection, and correction. NeuroImage, 17(4), 1820–1829.
Garavan, H., Kaufman, J. N., & Hester, R. (2008). Acute effects of cocaine on the neurobiology of cognitive control. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 363(1507), 3267–3276.
Ghitza, U. E., Preston, K. L., Epstein, D. H., Kuwabara, H., Endres, C. J., Bencherif, B., et al. (2010). Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biological Psychiatry, 68(8), 697–703.
Goldstein, R. Z., & Volkow, N. D. (2002). Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. The American Journal of Psychiatry, 159, 1642–1652.
Goldstein, R. Z., Leskovjan, A. C., Hoff, A. L., Hitzemann, R., Bashan, F., Khalsa, S. S., et al. (2004). Severity of neuropsychological impairment in cocaine and alcohol addiction: Association with metabolism in the prefrontal cortex. Neuropsychologia, 42(11), 1447–1458.
Goldstein, R. Z., Tomasi, D., Alia-Klein, N., Cottone, L. A., Zhang, L., Telang, F., et al. (2007a). Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers. Drug and Alcohol Dependence, 87(2–3), 233–240.
Goldstein, R. Z., Tomasi, D., Rajaram, S., Cottone, L. A., Zhang, L., Maloney, T., et al. (2007b). Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience, 144(4), 1153–1159.
Goldstein, R. Z., Woicik, P. A., Maloney, T., Tomasi, D., Alia-Klein, N., Shan, J., et al. (2010). Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proceedings of the National Academy of Sciences of the United States of America, 107(38), 16667–16672.
Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., et al. (2006). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA: The Journal of the American Medical Association, 296(1), 47–55.
Gorelick, D. A., Kim, Y. K., Bencherif, B., Boyd, S. J., Nelson, R., Copersino, M., et al. (2005). Imaging brain mu-opioid receptors in abstinent cocaine users: Time course and relation to cocaine craving. Biological Psychiatry, 57(12), 1573–1582.
Grady, S. R., Salminen, O., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2010). Mouse striatal dopamine nerve terminals express alpha4alpha5beta2 and two stoichiometric forms of alpha4beta2*-nicotinic acetylcholine receptors. Journal of Molecular Neuroscience, 40(1–2), 91–95.
Gray, R., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996). Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature, 383(6602), 713–716.
Heidbreder, C. (2011). Advances in animal models of drug addiction. Current Topics in Behavioral Neurosciences, 7, 213–250.
Heil, S. H., Johnson, M. W., Higgins, S. T., & Bickel, W. K. (2006). Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addictive Behaviors, 31(7), 1290–1294.
Heimer, L., & Van Hoesen, G. W. (2006). The limbic lobe and its output channels: Implications for emotional functions and adaptive behavior. Neuroscience and Biobehavioral Reviews, 30(2), 126–147.
Heinz, A., Siessmeier, T., Wrase, J., Hermann, D., Klein, S., Grusser, S. M., et al. (2004). Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. The American Journal of Psychiatry, 161(10), 1783–1789.
Heinz, A., Reimold, M., Wrase, J., Hermann, D., Croissant, B., Mundle, G., et al. (2005). Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: A positron emission tomography study using carbon 11-labeled carfentanil. Archives of General Psychiatry, 62(1), 57–64.
Heishman, S. J., Schuh, K. J., Schuster, C. R., Henningfield, J. E., & Goldberg, S. R. (2000). Reinforcing and subjective effects of morphine in human opioid abusers: Effect of dose and alternative reinforcer. Psychopharmacology, 148(3), 272–280.
Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1991). Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience, 11(2), 563–583.
Hester, R., & Garavan, H. (2004). Executive dysfunction in cocaine addiction: Evidence for discordant frontal, cingulate, and cerebellar activity. Journal of Neuroscience, 24(49), 11017–11022.
Hester, R., Nestor, L., & Garavan, H. (2009). Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology, 34(11), 2450–2458.
Hill, J. L., & Zacny, J. P. (2000). Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychopharmacology, 152(1), 31–39.
Hoffman, W. F., Schwartz, D. L., Huckans, M. S., McFarland, B. H., Meiri, G., Stevens, A. A., et al. (2008). Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology, 201(2), 183–193.
Howell, L. L., & Kimmel, H. L. (2008). Monoamine transporters and psychostimulant addiction. Biochemical Pharmacology, 75(1), 196–217.
Huestis, M. A., Boyd, S. J., Heishman, S. J., Preston, K. L., Bonnet, D. L., Fur, G., et al. (2007). Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology, 194(4), 505–515.
Hunault, C. C., Mensinga, T. T., de Vries, I., Kelholt-Dijkman, H. H., Hoek, J., Kruidenier, M., et al. (2008). Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC. Psychopharmacology, 201(2), 171–181.
Janes, A. C., Pizzagalli, D. A., Richardt, S., deB Frederick, B., Chuzi, S., Pachas, G., et al. (2010). Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biological Psychiatry, 67(8), 722–729.
Jia, Z., Worhunsky, P. D., Carroll, K. M., Rounsaville, B. J., Stevens, M. C., Pearlson, G. D., et al. (2011). An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biological Psychiatry, 70(6), 553–560.
Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., Williams, K. E., et al. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA: The Journal of the American Medical Association, 296(1), 56–63.
Kaufman, J. N., Ross, T. J., Stein, E. A., & Garavan, H. (2003). Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. Journal of Neuroscience, 23(21), 7839–7843.
Klink, R., de Kerchove d’Exaerde, A., Zoli, M., & Changeux, J. P. (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. Journal of Neuroscience, 21(5), 1452–1463.
Knutson, B., Adams, C. M., Fong, G. W., & Hommer, D. (2001). Anticipation of increasing monetary reward selectively recruits nucleus accumbens. Journal of Neuroscience, 21(16), RC159.
Koob, G. F. (2004). A role for GABA mechanisms in the motivational effects of alcohol. Biochemical Pharmacology, 68(8), 1515–1525.
Koob, G. F., & Le Moal, M. (1997). Drug abuse: Hedonic homeostatic dysregulation. Science, 278(5335), 52–58.
Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35(1), 217–238.
Koob, G. F., Ahmed, S. H., Boutrel, B., Chen, S. A., Kenny, P. J., Markou, A., et al. (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience and Biobehavioral Reviews, 27(8), 739–749.
Kosowski, A. R., & Liljequist, S. (2005). Behavioural sensitization to nicotine precedes the onset of nicotine-conditioned locomotor stimulation. Behavioural Brain Research, 156(1), 11–17.
Kruzich, P. J., & See, R. E. (2001). Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior. Journal of Neuroscience, 21(14), RC155.
Kruzich, P. J., Congleton, K. M., & See, R. E. (2001). Conditioned reinstatement of drug-seeking behavior with a discrete compound stimulus classically conditioned with intravenous cocaine. Behavioral Neuroscience, 115(5), 1086–1092.
Kubler, A., Murphy, K., & Garavan, H. (2005). Cocaine dependence and attention switching within and between verbal and visuospatial working memory. European Journal of Neuroscience, 21(7), 1984–1992.
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991). The dopamine hypothesis of the reinforcing properties of cocaine. Trends in Neurosciences, 14(7), 299–302.
Langleben, D. D., Ruparel, K., Elman, I., Busch-Winokur, S., Pratiwadi, R., Loughead, J., et al. (2008). Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. The American Journal of Psychiatry, 165(3), 390–394.
Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., et al. (2009). Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. Journal of Neuroscience, 29(47), 14734–14740.
Leroy, C., Karila, L., Martinot, J. L., Lukasiewicz, M., Duchesnay, E., Comtat, C., et al. (2011). Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: A high-resolution PET study. Addiction Biology, 17(6):981–90.
Lingford-Hughes, A. R., Acton, P. D., Gacinovic, S., Suckling, J., Busatto, G. F., Boddington, S. J. A., Bullmore, E., Woodruff, P. W., Costa, D. C., Pilowsky, L. S., Ell, P. J., Marshall, E. J., & Kerwin, R. W. (1998). Reduced levels of the GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. The British Journal of Psychiatry, 173, 116–122.
Lingford-Hughes, A. R., Wilson, S. J., Cunningham, V. J., Feeney, A., Stevenson, B., Brooks, D. J., & Nutt, D. J. (2005). GABA-benzodiazepine receptor function in alcohol dependence: A combined 11C-flumazenil PET and pharmacodynamic study. Psychopharmacology, 180, 595–606.
Lingford-Hughes, A. R., Watson, B., Kalk, N., & Reid, A. (2010). Neuropharmacology of addiction and how it informs treatment. British Medical Bulletin, 96, 93–110.
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D. on behalf of expert group. (2012a). Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: Recommendations from BAP. Journal of Psychopharmacology, 26(7), 899–952.
Lingford-Hughes, A. R., Reid, A. G., Myers, J., Feeney, A., Hammers, A., Taylor, L. G., Rosso, L., Turkheimer, F., Brooks, D. J., Grasby, P., & Nutt, D. J. (2012b). A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced a5 benzodiazepine receptors in limbic regions. Journal of Psychopharmacology, 26(2), 273–281.
Lippiello, P., Letchworth, S. R., Gatto, G. J., Traina, V. M., & Bencherif, M. (2006). Ispronicline: A novel alpha4beta2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties. Journal of Molecular Neuroscience, 30(1–2), 19–20.
Luo, S., Ainslie, G., Giragosian, L., & Monterosso, J. R. (2011). Striatal hyposensitivity to delayed rewards among cigarette smokers. Drug and Alcohol Dependence, 116(1–3), 18–23.
Mameli-Engvall, M., Evrard, A., Pons, S., Maskos, U., Svensson, T. H., Changeux, J. P., et al. (2006). Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron, 50(6), 911–921.
Mansvelder, H. D., & McGehee, D. S. (2002). Cellular and synaptic mechanisms of nicotine addiction. Journal of Neurobiology, 53(4), 606–617.
Martinez, D., Gil, R., Slifstein, M., Hwang, D. R., Huang, Y., Perez, A., et al. (2005). Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biological Psychiatry, 58(10), 779–786.
Martinez, D., Narendran, R., Foltin, R. W., Slifstein, M., Hwang, D. R., Broft, A., et al. (2007). Amphetamine-induced dopamine release: Markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. The American Journal of Psychiatry, 164(4), 622–629.
Martinez, D., Greene, K., Broft, A., Kumar, D., Liu, F., Narendran, R., et al. (2009). Lower level of endogenous dopamine in patients with cocaine dependence: Findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. The American Journal of Psychiatry, 166(10), 1170–1177.
Martinez, D., Saccone, P. A., Liu, F., Slifstein, M., Orlowska, D., Grassetti, A., et al. (2011). Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: Commonalities and differences with other types of addiction. Biological Psychiatry, 71(3):192–8.
Masse, L. C., & Tremblay, R. E. (1997). Behavior of boys in kindergarten and the onset of substance use during adolescence. Archives of General Psychiatry, 54(1), 62–68.
Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3(11), e442.
Matthews, S. C., Simmons, A. N., Lane, S. D., & Paulus, M. P. (2004). Selective activation of the nucleus accumbens during risk-taking decision making. Neuroreport, 15(13), 2123–2127.
McClernon, F. J., Hiott, F. B., Liu, J., Salley, A. N., Behm, F. M., & Rose, J. E. (2007). Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: Results of a preliminary functional magnetic resonance imaging study. Addiction Biology, 12(3–4), 503–512.
Mei, W., Zhang, J. X., & Xiao, Z. (2010). Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: An uncontrolled trial. Neuroscience, 170(3), 808–815.
Moeller, F. G., Steinberg, J. L., Schmitz, J. M., Ma, L., Liu, S., Kjome, K. L., et al. (2010). Working memory fMRI activation in cocaine-dependent subjects: Association with treatment response. Psychiatry Research, 181(3), 174–182.
Monterosso, J. R., Ainslie, G., Xu, J., Cordova, X., Domier, C. P., & London, E. D. (2007). Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Human Brain Mapping, 28(5), 383–393.
Muraven, M. (2010). Practicing self-control lowers the risk of smoking lapse. Psychology of Addictive Behaviors, 24(3), 446–452.
Myers, M. G., Brown, S. A., & Mott, M. A. (1995). Preadolescent conduct disorder behaviors predict relapse and progression of addiction for adolescent alcohol and drug abusers. Alcoholism, Clinical and Experimental Research, 19(6), 1528–1536.
Myrick, H., Anton, R. F., Li, X., Henderson, S., Randall, P. K., & Voronin, K. (2008). Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Archives of General Psychiatry, 65(4), 466–475.
Myrick, H., Li, X., Randall, P. K., Henderson, S., Voronin, K., & Anton, R. F. (2010). The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. Journal of Clinical Psychopharmacology, 30(4), 365–372.
Naqvi, N. H., & Bechara, A. (2008). The hidden island of addiction: The insula. Trends in Neurosciences, 32(1):56–67.
Nestor, L., Hester, R., & Garavan, H. (2010). Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. NeuroImage, 49(1), 1133–1143.
Nestor, L., McCabe, E., Jones, J., Clancy, L., & Garavan, H. (2011a). Differences in “bottom-up” and “top-down” neural activity in current and former cigarette smokers: Evidence for neural substrates which may promote nicotine abstinence through increased cognitive control. NeuroImage, 56(4), 2258–2275.
Nestor, L. J., Ghahremani, D. G., Monterosso, J., & London, E. D. (2011b). Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Research, 194(3), 287–295.
Nutt, D. J., & Lingford-Hughes, A. R. (2008). Addiction: The clinical interface. British Journal of Pharmacology, 154(2), 397–405.
Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419–427.
Pastor, V., Andres, M. E., & Bernabeu, R. O. (2012). The effect of previous exposure to nicotine on nicotine place preference. Psychopharmacology (Berlin), 226(3):551–60.
Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., et al. (2009). Varenicline improves mood and cognition during smoking abstinence. Biological Psychiatry, 65(2), 144–149.
Paulus, M. P., Hozack, N., Frank, L., Brown, G. G., & Schuckit, M. A. (2003). Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biological Psychiatry, 53(1), 65–74.
Paulus, M. P., Tapert, S. F., & Schuckit, M. A. (2005). Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Archives of General Psychiatry, 62(7), 761–768.
Peters, J., Bromberg, U., Schneider, S., Brassen, S., Menz, M., Banaschewski, T., et al. (2011). Lower ventral striatal activation during reward anticipation in adolescent smokers. The American Journal of Psychiatry, 168(5), 540–549.
Peto, R., Lopez, A. D., Boreham, J., Thun, M., Heath, C., Jr., & Doll, R. (1996). Mortality from smoking worldwide. British Medical Bulletin, 52(1), 12–21.
Reynolds, B., & Fields, S. (2011). Delay discounting by adolescents experimenting with cigarette smoking. Addiction, 107(2):417–24.
Ridderinkhof, K. R., Ullsperger, M., Crone, E. A., & Nieuwenhuis, S. (2004a). The role of the medial frontal cortex in cognitive control. Science, 306(5695), 443–447.
Ridderinkhof, K. R., van den Wildenberg, W. P., Segalowitz, S. J., & Carter, C. S. (2004b). Neurocognitive mechanisms of cognitive control: The role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain and Cognition, 56(2), 129–140.
Robinson, T. E., & Berridge, K. C. (2000). The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction, 95(Suppl 2), S91–S117.
Robles, E., Huang, B. E., Simpson, P. M., & McMillan, D. E. (2011). Delay discounting, impulsiveness, and addiction severity in opioid-dependent patients. Journal of Substance Abuse Treatment, 41(4), 354–362.
Rudnick, G., & Clark, J. (1993). From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters. Biochimica et Biophysica Acta, 1144(3), 249–263.
Schoenmakers, T. M., de Bruin, M., Lux, I. F., Goertz, A. G., Van Kerkhof, D. H., & Wiers, R. W. (2010). Clinical effectiveness of attentional bias modification training in abstinent alcoholic patients. Drug and Alcohol Dependence, 109(1–3), 30–36.
Schott, B. H., Minuzzi, L., Krebs, R. M., Elmenhorst, D., Lang, M., Winz, O. H., et al. (2008). Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. Journal of Neuroscience, 28(52), 14311–14319.
Sevy, S., Smith, G. S., Ma, Y., Dhawan, V., Chaly, T., Kingsley, P. B., et al. (2008). Cerebral glucose metabolism and D(2)/D (3) receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology, 197(4), 549–556.
Shaham, Y., Shalev, U., Lu, L., De Wit, H., & Stewart, J. (2003). The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology, 168(1–2), 3–20.
Shoptaw, S., Heinzerling, K. G., Rotheram-Fuller, E., Kao, U. H., Wang, P. C., Bholat, M. A., et al. (2008). Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. Journal of Addictive Diseases, 27(1), 13–23.
Sieghart, W. (2006). Structure, pharmacology, and function of GABAA receptor subtypes. Advances in Pharmacology, 54, 231–263.
Sinha, R., & Li, C. S. (2007). Imaging stress- and cue-induced drug and alcohol craving: Association with relapse and clinical implications. Drug and Alcohol Review, 26(1), 25–31.
Solomon, R. L., & Corbit, J. D. (1974). An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychological Review, 81(2), 119–145.
Sora, I., Li, B., Fumushima, S., Fukui, A., Arime, Y., Kasahara, Y., et al. (2009). Monoamine transporter as a target molecule for psychostimulants. International Review of Neurobiology, 85, 29–33.
Sticht, M., Mitsubata, J., Tucci, M., & Leri, F. (2010). Reacquisition of heroin and cocaine place preference involves a memory consolidation process sensitive to systemic and intra-ventral tegmental area naloxone. Neurobiology of Learning and Memory, 93(2), 248–260.
Stokes, P. R., Mehta, M. A., Curran, H. V., Breen, G., & Grasby, P. M. (2009). Can recreational doses of THC produce significant dopamine release in the human striatum? NeuroImage, 48(1), 186–190.
Stokes, P. R. A., Egerton, A., Watson, B., Reid, A., Lappin, J., Nutt, D., & Lingford-Hughes, A. (2012). History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. Journal of Psychopharmacology, 26(1), 144–149.
Sullivan, J. M., Risacher, S. L., Normandin, M. D., Yoder, K. K., Froehlich, J. C., & Morris, E. D. (2011). Imaging of alcohol-induced dopamine release in rats: Preliminary findings with [(11) C]raclopride PET. Synapse, 65(9), 929–937.
Tang, A., George, M. A., Randall, J. A., & Gonzales, R. A. (2003). Ethanol increases extracellular dopamine concentration in the ventral striatum in C57BL/6 mice. Alcoholism, Clinical and Experimental Research, 27(7), 1083–1089.
Thorn, D. A., Winter, J. C., & Li, J. X. (2012). Agmatine attenuates methamphetamine-induced conditioned place preference in rats. European Journal of Pharmacology, 680(1–3), 69–72.
Tomasi, D., Goldstein, R. Z., Telang, F., Maloney, T., Alia-Klein, N., Caparelli, E. C., et al. (2007). Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence. Brain Research, 1171, 83–92.
Tsou, K., Brown, S., Sanudo-Pena, M. C., Mackie, K., & Walker, J. M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83(2), 393–411.
Ullsperger, M., & von Cramon, D. Y. (2001). Subprocesses of performance monitoring: A dissociation of error processing and response competition revealed by event-related fMRI and ERPs. NeuroImage, 14(6), 1387–1401.
van Hell, H. H., Vink, M., Ossewaarde, L., Jager, G., Kahn, R. S., & Ramsey, N. F. (2010). Chronic effects of cannabis use on the human reward system: An fMRI study. European Neuropsychopharmacology, 20(3), 153–163.
Vanderschuren, L. J., & Kalivas, P. W. (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies. Psychopharmacology, 151(2–3), 99–120.
Verdejo-Garcia, A., & Bechara, A. (2009). A somatic marker theory of addiction. Neuropharmacology, 56(Suppl 1), 48–62.
Verney, S. P., Brown, G. G., Frank, L., & Paulus, M. P. (2003). Error-rate-related caudate and parietal cortex activation during decision making. Neuroreport, 14(7), 923–928.
Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Hitzemann, R., Ding, Y. S., et al. (1996). Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcoholism, Clinical and Experimental Research, 20(9), 1594–1598.
Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., et al. (1997). Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature, 386(6627), 830–833.
Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Gatley, S. J., Wong, C., et al. (1999). Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. Journal of Pharmacology and Experimental Therapeutics, 291(1), 409–415.
Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Ding, Y. S., Sedler, M., et al. (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. The American Journal of Psychiatry, 158(12), 2015–2021.
Volkow, N., Fowler, J., Wang, G., & Goldstein, R. (2002a). Role of dopamine, the frontal cortex and memory circuits in drug addiction: Insight from imaging studies. Neurobiology of Learning and Memory, 78(3), 610–624.
Volkow, N. D., Wang, G. J., Maynard, L., Fowler, J. S., Jayne, B., Telang, F., et al. (2002b). Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: A preliminary study. Psychiatry Research, 116(3), 163–172.
Volkow, N. D., Fowler, J. S., Wang, G. J., & Swanson, J. M. (2004). Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Molecular Psychiatry, 9(6), 557–569.
Volkow, N. D., Wang, G. J., Begleiter, H., Porjesz, B., Fowler, J. S., Telang, F., et al. (2006a). High levels of dopamine D2 receptors in unaffected members of alcoholic families: Possible protective factors. Archives of General Psychiatry, 63(9), 999–1008.
Volkow, N. D., Wang, G. J., Telang, F., Fowler, J. S., Logan, J., Childress, A. R., et al. (2006b). Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction. Journal of Neuroscience, 26(24), 6583–6588.
Volkow, N. D., Wang, G. J., Telang, F., Fowler, J. S., Logan, J., Jayne, M., et al. (2007). Profound decreases in dopamine release in striatum in detoxified alcoholics: Possible orbitofrontal involvement. Journal of Neuroscience, 27(46), 12700–12706.
Vollstadt-Klein, S., Wichert, S., Rabinstein, J., Buhler, M., Klein, O., Ende, G., et al. (2010). Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. Addiction, 105(10), 1741–1749.
Weerts, E. M., Wand, G. S., Kuwabara, H., Munro, C. A., Dannals, R. F., Hilton, J., et al. (2011). Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcoholism, Clinical and Experimental Research, 35(12), 2162–2173.
Weiss, F., Maldonado-Vlaar, C. S., Parsons, L. H., Kerr, T. M., Smith, D. L., & Ben-Shahar, O. (2000). Control of cocaine-seeking behavior by drug-associated stimuli in rats: Effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America, 97(8), 4321–4326.
Wexler, B. E., Gottschalk, C. H., Fulbright, R. K., Prohovnik, I., Lacadie, C. M., Rounsaville, B. J., et al. (2001). Functional magnetic resonance imaging of cocaine craving. The American Journal of Psychiatry, 158(1), 86–95.
Williams, T. M., Daglish, M. R. C., Lingford-Hughes, A. R., Taylor, L. G., Hammers, A., Brooks, D. J., Grasby, P. G., Myles, J. S., & Nutt, D. J. (2007). Increased availability of opioid receptors in early abstinence from opioid dependence: A [11C]diprenorphine PET study. The British Journal of Psychiatry, 191(1), 63–69.
Williams, T. M., Davies, S. J., Taylor, L. G., Daglish, M. R., Hammers, A., Brooks, D. J., Nutt, D. J., & Lingford-Hughes, A. (2009). Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [(11)C]diprenorphine PET study. European Neuropsychopharmacology, 19(10), 740–748.
Wise, R. A. (1996). Neurobiology of addiction. Current Opinion in Neurobiology, 6(2), 243–251.
Wise, R. A. (2002). Brain reward circuitry: Insights from unsensed incentives. Neuron, 36(2), 229–240.
Wise, R. A. (2005). Forebrain substrates of reward and motivation. The Journal of Comparative Neurology, 493(1), 115–121.
Wooltorton, J. R., Pidoplichko, V. I., Broide, R. S., & Dani, J. A. (2003). Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. Journal of Neuroscience, 23(8), 3176–3185.
Woolverton, W. L., & Johnson, K. M. (1992). Neurobiology of cocaine abuse. Trends in Pharmacological Sciences, 13(5), 193–200.
Wrase, J., Schlagenhauf, F., Kienast, T., Wustenberg, T., Bermpohl, F., Kahnt, T., et al. (2007). Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. NeuroImage, 35(2), 787–794.
Yahyavi-Firouz-Abadi, N., & See, R. E. (2009). Anti-relapse medications: Preclinical models for drug addiction treatment. Pharmacology & Therapeutics, 124(2), 235–247.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Lingford-Hughes, A., Nestor, L. (2015). Neuroscience Perspectives on Addiction: Overview. In: Clausen, J., Levy, N. (eds) Handbook of Neuroethics. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4707-4_68
Download citation
DOI: https://doi.org/10.1007/978-94-007-4707-4_68
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4706-7
Online ISBN: 978-94-007-4707-4
eBook Packages: Humanities, Social Sciences and Law